Targeting inhibitor 2 of protein phosphatase 2A as a therapeutic strategy for prostate cancer treatment.
about
Regulation of PP2A by Sphingolipid Metabolism and SignalingAssociation between SET expression and glioblastoma cell apoptosis and proliferation.Downregulation of Critical Oncogenes by the Selective SK2 Inhibitor ABC294640 Hinders Prostate Cancer Progression.Ceramide in the prostate.Macrocyclic peptides decrease c-Myc protein levels and reduce prostate cancer cell growth.PP2A inhibition as a novel therapeutic target in castration-resistant prostate cancer.
P2860
Targeting inhibitor 2 of protein phosphatase 2A as a therapeutic strategy for prostate cancer treatment.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Targeting inhibitor 2 of prote ...... for prostate cancer treatment.
@en
Targeting inhibitor 2 of prote ...... for prostate cancer treatment.
@nl
type
label
Targeting inhibitor 2 of prote ...... for prostate cancer treatment.
@en
Targeting inhibitor 2 of prote ...... for prostate cancer treatment.
@nl
prefLabel
Targeting inhibitor 2 of prote ...... for prostate cancer treatment.
@en
Targeting inhibitor 2 of prote ...... for prostate cancer treatment.
@nl
P2093
P2860
P356
P1476
Targeting inhibitor 2 of prote ...... for prostate cancer treatment.
@en
P2093
Archana Mukhopadhyay
Jane V Aldrich
Kayann Tabanor
Rathnam Chaguturu
P2860
P304
P356
10.4161/CBT.25943
P577
2013-08-05T00:00:00Z